Claritev (CTEV) Q1 Revenue $244.7M, Raises 2026 Guidance to $985M
Published on 5/9/2026

AI Summary
Summarized by AI from the source belowClaritev (CTEV) reported Q1 2026 revenue of $244.7 million, up 5.8% year over year, and adjusted EBITDA of $146.9 million, reflecting a 60% margin and a 3.4% increase from the previous year. The company raised its 2026 revenue guidance to a range of $985 million to $1 billion, with bookings hitting a record $44.1 million in annual contract value. Management indicated a strong sales momentum due to a 70% year-over-year pipeline growth and increased cross-sell and upsell activities, comprising 73% of bookings. Claritev also closed 19 deals over $100,000 and nine over $1 million, marking a 350% rise in seven-figure deals.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
Related News

Cardinal Health Raises Price Target After Positive Profit Guidance
Aug 11

Hnit-Baltic Uab Announcement: Financial Performance Updates
Aug 11

Travere Therapeutics (TVTX) Expands Focus on Rare Disease Treatments
Aug 11

Amazon (AMZN) Shares: Jeff Bezos Sells Over $4 Billion Worth
Aug 11